Rationale and design of a type 2 diabetes prevention intervention for at-risk mothers and children at a Federally Qualified Healthcare Center: EPIC El Rio Families Study Protocol
Name:
s12889-021-10392-w.pdf
Size:
688.6Kb
Format:
PDF
Description:
Final Published Version
Author
Marrero, David G.Blew, Robert M.
Palmer, Kelly N. B.
James, Kyla
Roe, Denise J.
Hingle, Melanie D.
Affiliation
University of Arizona Health Sciences Center for Border Health DisparitiesDepartment of Nutritional Sciences, College of Agriculture & Life Sciences, The University of Arizona
University of Arizona Collaboratory for Metabolic Disease and Prevention, Abrams Public Health Center
Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, The University of Arizona
Issue Date
2021-02-12Keywords
Body weightChild
Diabetes mellitus, type 2
Diabetes, gestational
Life style
Mothers
Preventive health
Primordial prevention
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Marrero, D. G., Blew, R. M., Palmer, K. N., James, K., Roe, D. J., & Hingle, M. D. (2021). Rationale and design of a type 2 diabetes prevention intervention for at-risk mothers and children at a Federally Qualified Healthcare Center: EPIC El Rio Families Study Protocol. BMC Public Health, 21(1), 1-9.Journal
BMC Public HealthRights
© The Author(s). 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Exposure to gestational diabetes mellitus (GDM) is associated with increased risk for type 2 diabetes (T2DM) in mothers, and poor cardiovascular health among offspring. Identifying effective methods to mitigate T2DM risk has the potential to improve health outcomes for mothers with a history of GDM and their children. The goal of the EPIC El Rio Families Study is to implement and evaluate the effects of a 13-week behavioral lifestyle intervention on T2DM risk factors in at-risk mothers and their 8- to 12-year-old children. We describe herein the rationale for our specific approach, the adaption of the DPP-based curriculum for delivery to patients of a Federally Qualified Health Center (FQHC), and the study design and methodology. Methods: The effects of the intervention on reduction in excess body weight (primary outcome), hemoglobin A1c, blood pressure, and changes in lifestyle behaviors associated with weight trajectory and T2DM risk in mother-child dyads will be evaluated during a 13-week, group randomized trial wherein 60 mothers and their children will be recruited to the intervention or wait-listed control conditions at one of two FQHC locations. Intervention participants (n = 30) will begin the group program immediately, whereas the wait-listed controls (n = 30) will receive a booklet describing self-guided strategies for behavior change. Associated program delivery costs, acceptability of the program to participants and FQHC staff, and potential for long-term sustainability will also be evaluated. Discussion: Successful completion in our aims will produce a scalable program with high potential for replication and dissemination, and estimated intervention effects to inform T2DM prevention efforts on families who use the FQHC system. The results from this study will be critical in developing a T2DM prevention model that can be implemented and scaled across FQHCs serving populations disproportionately burdened by T2DM. Trial registration: ClinicalTrials.gov NCT03781102; Date of registration: 19 December 2018. © 2021, The Author(s).Note
Open access journalISSN
1471-2458EISSN
1471-2458Version
Final published versionSponsors
National Institute of Diabetes and Digestive and Kidney Diseasesae974a485f413a2113503eed53cd6c53
10.1186/s12889-021-10392-w
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s). 2021. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.